February 10, 2014
Affygility Solutions, the leading provider of environmental, health and safety (EHS) software and consulting services to the life sciences industry, today announced the launch of its Qualitative Exposure Assessment (QEA) module. This qualitative exposure assessment module will assist life science companies in evaluating the overall risk of occupational exposure to active pharmaceutical ingredients, otherwise know as "potent compounds."
"Based on decades of experience in the life science industry, our web-based qualitative exposure assessment tool makes it easy for EHS professionals to evaluate if additional health and safety controls are required when working with potent compounds." says Dean Calhoun, CIH, President and CEO at Affygility Solutions. "Our goal at Affygility Solutions is to make it easy for the working EHS professional to ensure the safety of life-science workers and comply with state and federal regulations."
This qualitative exposure assessment tool is offered as part of the Affytrac EHS software system, an enterprise, web-based EHS software suite. Affytrac supports EHS professionals and corporate management by efficiently tracking and reporting all the essential data required for compliance in a regulated research and manufacturing settings. Other modules in the suite include EHS task management and corrective action management.
"Since 2012, with their OEL Fastrac monographs, Affygility Solutions has provided life-science companies with an efficient, web-based solution for purchasing occupational exposure limit (OEL) and acceptable daily exposure (ADE) value monographs for potent compounds" says Chris Tompkins, a member of the Affygility Board. "Now with the QEA module, the company is providing a complete potent compound management solution to the life science industry"